Research Paper Volume 16, Issue 3 pp 2591—2616
Prognostic model development and molecular subtypes identification in bladder urothelial cancer by oxidative stress signatures
Figure 11. Enrichment pathways for GSVA. The correlation between pathways (A), immune hallmarks (B) and risk scores in the KEGG database. (C) The correlation between immune checkpoint blockade genes and risk scores to predict immunotherapy response. (D) The chemotherapy efficiency estimation in the IPS score distribution map. (E) Cisplatin, (F) Docelaxel and (G) methotrexate sensitivity in the low and high groups.